These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32194194)

  • 1. Blood fatty acids in Alzheimer's disease and mild cognitive impairment: A meta-analysis and systematic review.
    Hosseini M; Poljak A; Braidy N; Crawford J; Sachdev P
    Ageing Res Rev; 2020 Jul; 60():101043. PubMed ID: 32194194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The shift in the fatty acid composition of the circulating lipidome in Alzheimer's disease.
    Dakterzada F; Jové M; Cantero JL; Mota-Martorell N; Pamplona R; Piñoll-Ripoll G
    Alzheimers Dement; 2024 May; 20(5):3322-3333. PubMed ID: 38534027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment.
    Conquer JA; Tierney MC; Zecevic J; Bettger WJ; Fisher RH
    Lipids; 2000 Dec; 35(12):1305-12. PubMed ID: 11201991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease.
    Abdullah L; Evans JE; Emmerich T; Crynen G; Shackleton B; Keegan AP; Luis C; Tai L; LaDu MJ; Mullan M; Crawford F; Bachmeier C
    Aging (Albany NY); 2017 Mar; 9(3):964-985. PubMed ID: 28333036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease.
    Cunnane SC; Schneider JA; Tangney C; Tremblay-Mercier J; Fortier M; Bennett DA; Morris MC
    J Alzheimers Dis; 2012; 29(3):691-7. PubMed ID: 22466064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fatty acids and risk for Alzheimer's disease, dementia, and mild cognitive impairment: A prospective cohort meta-analysis.
    Zhu RZ; Chen MQ; Zhang ZW; Wu TY; Zhao WH
    Nutrition; 2021 Oct; 90():111355. PubMed ID: 34218119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Homocysteine and Serum Folate and Vitamin B
    Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
    Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
    Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.
    Ng TKS; Ho CSH; Tam WWS; Kua EH; Ho RC
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts.
    Muenchhoff J; Poljak A; Song F; Raftery M; Brodaty H; Duncan M; McEvoy M; Attia J; Schofield PW; Sachdev PS
    J Alzheimers Dis; 2015; 43(4):1355-73. PubMed ID: 25159666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis.
    Xie B; Zhou H; Liu W; Yu W; Liu Z; Jiang L; Zhang R; Cui D; Shi Z; Xu S
    Int J Neurosci; 2020 Mar; 130(3):218-230. PubMed ID: 31518516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum TC and LDL-C levels in Alzheimer's disease and mild cognitive impairment: A meta-analysis study.
    Liu Y; Zhong X; Shen J; Jiao L; Tong J; Zhao W; Du K; Gong S; Liu M; Wei M
    Brain Res; 2020 Jan; 1727():146554. PubMed ID: 31765631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Serum Manganese Levels with  Alzheimer's Disease and Mild Cognitive Impairment:  A Systematic Review and Meta-Analysis.
    Du K; Liu M; Pan Y; Zhong X; Wei M
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28273828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
    Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
    Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease.
    Fonteh AN; Cipolla M; Chiang J; Arakaki X; Harrington MG
    PLoS One; 2014; 9(6):e100519. PubMed ID: 24956173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer's disease.
    Iuliano L; Pacelli A; Ciacciarelli M; Zerbinati C; Fagioli S; Piras F; Orfei MD; Bossù P; Pazzelli F; Serviddio G; Caltagirone C; Spalletta G
    J Alzheimers Dis; 2013; 36(3):545-53. PubMed ID: 23635405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
    Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
    J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corpus callosum atrophy associated with the degree of cognitive decline in patients with Alzheimer's dementia or mild cognitive impairment: a meta-analysis of the region of interest structural imaging studies.
    Wang XD; Ren M; Zhu MW; Gao WP; Zhang J; Shen H; Lin ZG; Feng HL; Zhao CJ; Gao K
    J Psychiatr Res; 2015 Apr; 63():10-9. PubMed ID: 25748753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Nutr Neurosci; 2012 Nov; 15(6):271-7. PubMed ID: 22824373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.